One-Week Countdown: Community Risk Assessment Tool review Kick-Off Next Wednesday 13-August-25!
@Nitrosamines_Analyzer @trust_level_2 @trust_level_3
We’re thrilled to announce that our very first crowdsourcing initiative—the USP’s Nitrosamine Risk-Assessment Tool review—goes live next Wednesday, August 13 (10:00 AM EDT) with a special kick-off briefing right here in Nitrosamines Exchange.
What to expect at the briefing
| Time | Segment | Speakers |
|---|---|---|
| 10:00 – 10:10 | Welcome & objectives | Naiffer (Community Manager) |
| 10:10 – 10:20 | Tool overview & crowdsourcing workflow | Core Development Team |
| 10:20 – 10:50 | Module spotlights | |
| • Drug Substance | ||
| • Drug Product | ||
| • Excipient | ||
| 10:50 – 11:00 | Next steps & closing | Naiffer |
Why your participation matters
- Real-world validation. Your day-to-day experiences will stress-test the tool far better than any internal simulation.
- Shape best practice. Insights you share today will inform tomorrow’s guidance for the entire industry.
- Collective impact. When 5,000+ scientists pool knowledge, we accelerate safer medicines for millions of patients.
How you can be part of it
Register here for the kick off session:
https://event.webinarjam.com/register/2/y613mu7
- Join the kick-off session (add it to your calendar now—link in comments).
- Opt-in after the briefing—agree to the contributor terms and request access to the closed review group.
- Dive deep with the team. Each module lead will guide you through background, considerations, and real-life examples to get you started.
- Test, discuss, improve. Over the following weeks we’ll meet regularly, collect feedback, and iterate fast.
We count on the whole community’s support to turn this practical tool into a gold-standard resource. Mark your calendars, and get ready to roll up your sleeves—together we’ll move from “what” to the actionable “how.”
See you next Wednesday! 
– Naiffer & the USP Nitrosamine Team
Important: This is not a compendial ballot, revision request, or standard-setting process. It’s a peer-to-peer exchange—just like every other collaborative thread in Nitrosamines Exchange. Confidential data should not be shared.
